Skip to content

Try Ageless review

By Marcus HaleLongevity Research Editor
Updated

An open FDA letter, and no advertised figure the seller calls final

The FDA issued a warning letter in September 2025 to Lovely Meds, Inc. dba Lovely Meds — the entity Try Ageless's own regulation page names as operating its website — and the FDA's public list does not show it as closed out. Separately, $249 is the list price, $199 is an intro-code rate, and the site says the real amount is set after clinical review.

$249/mo ($199 intro code)

FDA warning letter. The FDA issued a warning letter to Lovely Meds, Inc. dba Lovely Meds in September 2025. The agency's index does not record it as closed out. You can look it up on the FDA’s warning-letter index.

We may earn a commission if you sign up through our links, at no cost to you. How we make money.

Key details

Advertised price
NAD+ listed at $249/month, advertised at $199 with an introductory code, alongside the site's own statement that the final amount is set after clinical review.
Billing details
Not determinable from the public site. The seller states the amount is set after clinical review, so $199 and $249 are both provisional.
Pharmacy
Seven are named — The Pharmacy Hub LLC, Greenwich Rx, VialsRX, Partell Specialty, Believe Rx, Precision Compounding Pharmacy & Wellness and HealthWarehouse.com. None carries a published 503A or 503B designation. Two clinicians are named and both check out in the national registry: Michael Wasef MD (NPI 1417261926, internal medicine, Florida) and Jonah Mink MD (NPI 1083052351). Against that, its medical-experts page is unedited template filler — one name appears twice under two different specialties, and the testimonials carry stock placeholder names.
Availability
Not published — no list exists anywhere on the site. Its own peptide page claims "State-smart — We tell you what's available in your state upfront". It does not.
Comparison
Listed on our NAD+ provider index.

Our verdict

Start with the fact that decides whether the rest matters. In September 2025 the FDA issued a warning letter to Lovely Meds, Inc. dba Lovely Meds — and that is not a name resemblance: Try Ageless's own regulation page states that "Try Ageless is a brand operated by Lovely Meds, Inc." and that its website is managed under that entity. The FDA's public list does not show the letter as closed out. On the commercial side, Try Ageless sells compounded NAD+ as an injection and as a troche, inside a broader longevity and weight-loss menu. It deserves credit for one unusual admission: the site states that the final amount is determined after clinical review, which is more honest than letting an intro rate stand as though it were the price. The result, though, is that nothing it advertises is a price. $249 is the list, $199 is what an introductory code produces, and the number you pay is decided later. Try Ageless also runs a shop with per-dose pricing alongside a plan sign-up with different figures for the same molecule, so comparison shopping is close to impossible from the outside.

NAD+ evidence

Compounded NAD+ is not an FDA-approved product, and the route sold here has no randomized human trial behind it: there is no published study showing that subcutaneous or intranasal NAD+ raises blood NAD+ in people, let alone that it improves energy, focus or any aging endpoint. What the clinical literature actually supports is the oral precursor NR, which does raise blood NAD+ in controlled trials — a different molecule by a different route. The troche is worth a separate note: a buccal or sublingual troche is neither an injection nor a capsule, and there is no human study showing that buccal NAD+ raises blood NAD+ either. "Needle-free" is a convenience claim, not an absorption one.

Pricing and fees

Advertised price
NAD+ listed at $249/month, advertised at $199 with an introductory code, alongside the site's own statement that the final amount is set after clinical review.
Payment terms
Not determinable from the public site. The seller states the amount is set after clinical review, so $199 and $249 are both provisional.
Pricing details
Introductory-code pricing on top of a list price, with the real figure decided after intake. Try Ageless also runs two separate price structures under the same brand — a shop with standing per-dose prices and a plan sign-up with its own, higher month-to-month rates that fall on longer commitments — so which number applies depends on where you start.

Additional fees

  • The introductory code applies to a first order, not to the standing rate
  • No membership fee is published

Prices are from Try Ageless's own website and can change without notice.

Who it may suit

May suit you if

  • You want a troche rather than an injection and cannot find one elsewhere
  • You want NAD+ inside a broader longevity menu from one provider
  • You are comfortable discovering your actual price during clinical review

Consider another option if

  • You want to budget before you start — no published figure here is final by the seller's own statement
  • You want one price structure: the shop and the plan funnel price the same products differently
  • You want a named pharmacy or a 503A/503B designation
  • You want to compare against this site's other providers on a like-for-like number

What’s included

Consultation
Yes — clinical review precedes dispensing, and the site states the final price is set at that point.
Lab testing
Optional; no lab gate is published for the NAD+ line.
Follow-up care
Not published for the NAD+ line.
Clinical support
No dietitian or coaching program is part of the offer.
Supplies
Not itemized publicly for the injection.
Shipping
Not itemized publicly for the NAD+ line.

Limitations and policy details

The FDA issued a warning letter in September 2025 to Lovely Meds, Inc. dba Lovely Meds, the entity Try Ageless's own regulation page names as the operator of its website, and the FDA's public list does not show it as closed out. We will not characterize the agency's case here — the letter is public and makes it better than a paraphrase would — but its existence, its date and its open status matter to anyone about to hand this company a payment and a medical history. Be aware that the letter is listed under the name "Lovely Meds", which the Try Ageless storefront never uses, so searching the FDA's list for the brand name will not find it. Beyond the letter: by Try Ageless's own account no published figure is the price, so every number on its marketing pages is an advertisement rather than an offer. And Try Ageless is a completely different company from AgelessRx, which we review separately. They are not affiliated and their pricing has nothing to do with one another.

Other considerations

  • An FDA warning letter issued in September 2025 to Lovely Meds, Inc. dba Lovely Meds — the entity Try Ageless's own regulation page names as operating its website — is on the agency's public record and is not shown as closed out
  • Its LegitScript seal does not currently verify, so we do not describe Try Ageless as LegitScript certified
  • The seller states the final amount is set after clinical review, so no advertised figure is binding
  • Two parallel price structures — a per-dose shop and a plan sign-up — for the same products
  • Seven pharmacies are named but none is categorized 503A or 503B, and no state list is published anywhere

Cost calculators

How this site makes money

We may earn a commission when you buy a product or start care through our links, at no extra cost to you. Affiliate partners appear first in our provider comparison. Read the full disclosure.

View Try Ageless

Every figure on this page comes from Try Ageless’s own site, and prices change without notice. Compare it against the rest of the field on our NAD+ provider index, or read every provider review.

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.